Exploring Aramchol – Lessons Learned & Optimization Towards Registrational Part of Phase 3 Clinical Study

Time: 2:30 pm
day: Day 1 Stream 3 PM

Details:

• Explaining liver fibrosis – from basic pathophysiology to mechanism of action of drug candidates.
• Targeting liver fibrosis: Understanding its main challenges.
• Aramchol 101: Discovering its mechanism of action, compound optimization, and resulting clinical efficacy.

Speakers: